Floatz logo

203 assets in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Therapeutic assets addressing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tafasitamab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP2B (58)
Valganciclovir
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP4B (58)
Zilovertamab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
University of California, San DiegoP2B (58)
Thalidomide
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2B (56)
Ublituximab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
TG Therapeutics, Inc.P3B (56)
Thiotepa
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Baptist Health South FloridaP2CCC (55)
Atezolizumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Christine RyanP2CCC (54)
Abatacept Recombinant
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Center for International Blood and Marrow Transplant ResearchP2CCC (53)
Belimumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
University Hospital TuebingenP2CCC (53)
Letermovir
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP2CCC (53)
Nadravaleucel
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
David WaldP2CCC (53)
Ptcy
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Center for International Blood and Marrow Transplant ResearchP2CCC (53)
Azacitidine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Prelude TherapeuticsP2CCC (52)
Cart-19 Cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3CCC (52)
cd22 car-transduced t cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer CenterP1/2CCC (52)
Daratumumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mayo ClinicP2CCC (52)
Durvalumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mayo ClinicP2CCC (52)
Moderna Bivalent Mrna Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Monash UniversityP3CCC (52)
pf-05280586
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLCP3CCC (52)
Pfizer Bivalent Covid-19 Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Monash UniversityP3CCC (52)
Pneumococcal Polyvalent Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Seema BhatP2CCC (52)
Polatuzumab Vedotin
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Christine RyanP2CCC (52)
Rituximab Arrx
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLCP3CCC (52)
Rituximab Biosimilar (Celltrion)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLCP3CCC (52)
Tocilizumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Christine RyanP2CCC (52)
Zilovertamab Vedotin
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLCP2CCC (52)
Allopurinol
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (51)
Ruxolitinib Phosphate
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP2CCC (51)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Fred Hutchinson Cancer CenterP2CCC (50)
Mirdametinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
National Cancer Institute (NCI)P2CCC (50)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP2CCC (50)
Umbralisib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Weill Medical College of Cornell UniversityP3CCC (50)
zx-101a
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nanjing Zenshine PharmaceuticalsP1/2CCC (50)
Moderna Covid-19 Vaccine Rna
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Barbara Ann Karmanos Cancer InstituteP2CCC (49)
Mosunetuzumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Inhye AhnP1/2CCC (49)
Copanlisib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Inhye AhnP2CCC (48)
ctx112
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
CRISPR Therapeutics AGP1/2CCC (48)
Emavusertib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Curis, Inc.P2CCC (48)
Evusheld
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sunnybrook Health Sciences CentreP2CCC (48)
Gnc-035
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.P1/2CCC (48)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Christine RyanP2CCC (48)
Iopofosine (¹³¹I)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Cellectar Biosciences, Inc.P2CCC (48)
mb-106
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mustang BioP1/2CCC (48)
Multiple Vitamins Injection
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
University of UtahP2CCC (48)
Pneumococcal 20-Valent Conjugate Vaccine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Seema BhatP2CCC (48)
Recombinant Human Hyaluronidase
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Academic and Community Cancer Research UnitedP2CCC (48)
Synthetic Mva-Based Sars-Cov-2 Vaccine Geo-Cm04S1
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP2CCC (48)
Treosulfan
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Fred Hutchinson Cancer CenterP2CCC (48)
Aspartate Zinc
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Vector Vitale LLCP1/2CC (47)
Autologous Hucd19 Car T Cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
National Cancer Institute (NCI)P1/2CC (47)
Showing 51 to 100 of 203 assets
PreviousPage 2 of 5Next